You are here

diabetes

TWi Pharma's reduced food effect metformin controlled release formulation gets US patent

Pharmabiz

Sat, 07/20/13 - 12:07 pm

TWi Pharmaceuticals

Medical Pot: A Drugmaker Bets on Marijuana to Treat Diabetes, Epilepsy, and More

Bloomberg/Businessweek

Fri, 07/19/13 - 12:05 pm

multiple sclerosis

The Future of Sanofi's Insulin Empire

Motley Fool

Fri, 07/19/13 - 10:17 am

Sun Pharma gets USFDA nod for generic diabetes tablets

Zee News, India

Sat, 07/13/13 - 12:43 pm

Death Of A Drug Class Shows Difficulty Of Using Gene Data To Design Drugs

Forbes

Wed, 07/10/13 - 10:32 am

Merck's $5.7 Billion Diabetes Franchise Is Vulnerable

Seeking Alpha

Wed, 07/10/13 - 10:25 am

[video]Inhaled Insulin: Biotech Triumph or Future Flop?

Motley Fool

Mon, 07/8/13 - 10:37 am

inhaled insulin

Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product

Yahoo

Mon, 07/8/13 - 09:43 am

Boehringer Ingelheim

long-acting insulin

Sanofi's Lyxumia Gets Japanese Nod

Yahoo/Zacks

Wed, 07/3/13 - 11:11 am

Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market

Seeking Alpha

Fri, 06/28/13 - 10:13 am

Bristol-Myers Squibb

Is This What the Doctor Ordered for Eli Lilly?

Motley Fool

Thu, 06/27/13 - 08:55 pm

Bristol-Myers Squibb

Novo Nordisk Suspends Paula Deen As A Spokesperson

Pharmalot

Thu, 06/27/13 - 11:15 am

Merck & Co wins injunction against Indian firm over diabetes drugs

Reuters

Tue, 06/25/13 - 10:53 am

Aprica Pharmaceuticals

Glaxo Diabetes Drug Didn’t Beat Takeda's Actos in Trial

Bloomberg

Mon, 06/24/13 - 11:09 am

New GSK diabetes drug works, but faces tough competition

Reuters

Mon, 06/24/13 - 10:28 am

Bristol-Myers Squibb

Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300

Yahoo/Market Wired

Sun, 06/23/13 - 11:30 am

type 2 diabetes

Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes

Yahoo/PR NewsWire

Sun, 06/23/13 - 11:28 am

type 2 diabetes

Glaxo Diabetes Drug Shows Gastrointestinal Side Effects

Bloomberg

Sun, 06/23/13 - 11:22 am

type 2 diabetes

Phase III data show significant reductions in blood glucose with investigational compound empagliflozin used as monotherapy in adults with type 2 diabetes

Yahoo/PR NewsWire

Sun, 06/23/13 - 11:20 am

type 2 diabetes

Boehringer Ingelheim

Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541

Yahoo/PR NewsWire

Sun, 06/23/13 - 11:19 am

type 1 diabetes

Pages